Formulation and stability of naltrexone oral liquid for rapid withdrawal from methadone

Annals of Pharmacotherapy

Volumn 31, Issue 11, 1997, Pages 1291-1295

  Fawcett, J Paul ^a   Morgan, Nicola C ^a   Woods, David J ^a,b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b DUNEDIN HOSPITAL   (New Zealand)

Author keywords

Methadone; Naltrexone

Indexed keywords

METHADONE; NALTREXONE;

ARTICLE; DATA ANALYSIS; DECOMPOSITION; DOSE RESPONSE; DRUG FORMULATION; DRUG WITHDRAWAL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAINTENANCE THERAPY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TITRIMETRY;

EID: 0030665661     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809703101102     Document Type: Article

References (11)

1. Dole VP, Nyswander M. A medical treatment for diacetylmorphine (heroin) addiction: a clinical trial with methadone hydrochloride. JAMA 1965;193:646-50.
2. Christie MJ, Harvey AI. Pharmacological options for management of opioid dependence. Drug Alcohol Rev 1993;12:71-80.
3. Sellman D, Deering D, Robinson G. Methadone maintenance treatment: coming of age in New Zealand. N Z Med J 1995;108:128-30.
4. Resnick R, Schuyten-Resnick E, Washton A. Narcotic antagonists in the treatment of opioid dependence: review and commentary. Compr Psychiatry 1979;20:116-25.
5. Loimer N, Lenz K, Presslich O, Schmid R. Rapid transition from methadone maintenance to naltrexone (letter). Lancet 1990;335:111.
6. Gonsalez JP, Brogend RN. Naltrexone: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence. Drugs 1988;35:192-213.
7. Kosten TA, Kosten TR. Pharmacological blocking agents for treating substance abuse. J Nerv Ment Dis 1991;179:583-92.
8. Charney DS, Heninger GR, Kleber HD. The combined use of clonidine and naltrexone as a rapid, safe, and effective treatment of abrupt withdrawal from methadone. Am J Psychiatry 1986;143:831-7.
9. Brewer C, Rezae H, Bailey C. Opioid withdrawal and naltrexone induction in 48-72 hours with minimal drop-out, using a modification of the naltrexone-clonidine technique. Br J Psychiatry 1988;153:340-3.
10. Brewer C. Naltrexone: an "Antabuse" for heroin addicts? Pharm J 1987; 239:182-3.
11. Asali LA, Nation RL, Brown KF. Determination of naloxone in blood by high-performance liquid chromatography. J Chromatogr 1983;278:329-35.